Combined deficiency of xanthine oxidase and sulphite oxidase: a defect of molybdenum metabolism or transport? 1978

M Duran, and F A Beemer, and C van de Heiden, and J Korteland, and P K de Bree, and M Brink, and S K Wadman, and I Lombeck

A child is described who presented in the neonatal period with feeding difficulties, severe neurological abnormalities, lens dislocation of the eyes and dysmorphic symptoms of the head. Routine laboratory investigations revealed a decreased serum urate and a positive sulphite reaction of the urine. Subsequent chromatographic examinations showed xanthinuria and increased excretion of S-sulphocysteine and taurine to be present. In addition, high thiosulphate and low sulphate excretions in the urine were observed. Xanthine oxidase deficiency was demonstrated in a jejunal biopsy specimen, whereas the excretion of sulphur containing substances was considered to be characteristic of sulphite oxidase deficiency. This new combination of defects may be the result of malfunctioning of both enzymes, possibly caused by alterations in the essential molybdenum containing active centre of the enzymes, which they share in common.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008664 Metal Metabolism, Inborn Errors Dysfunctions in the metabolism of metals resulting from inborn genetic mutations that are inherited or acquired in utero. Metal Metabolism, Inborn Error
D008982 Molybdenum A metallic element with the atomic symbol Mo, atomic number 42, and atomic weight 95.95. It is an essential trace element, being a component of the enzymes xanthine oxidase, aldehyde oxidase, and nitrate reductase. Molybdenum-98,Molybdenum 98
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000015 Abnormalities, Multiple Congenital abnormalities that affect more than one organ or body structure. Multiple Abnormalities
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D014969 Xanthine Oxidase An iron-molybdenum flavoprotein containing FLAVIN-ADENINE DINUCLEOTIDE that oxidizes hypoxanthine, some other purines and pterins, and aldehydes. Deficiency of the enzyme, an autosomal recessive trait, causes xanthinuria. Hypoxanthine Oxidase,Hypoxanthine Dehydrogenase,Hypoxanthine-Xanthine Oxidase,Purine-Xanthine Oxidase,Dehydrogenase, Hypoxanthine,Hypoxanthine Xanthine Oxidase,Oxidase, Hypoxanthine,Oxidase, Hypoxanthine-Xanthine,Oxidase, Purine-Xanthine,Oxidase, Xanthine,Purine Xanthine Oxidase

Related Publications

M Duran, and F A Beemer, and C van de Heiden, and J Korteland, and P K de Bree, and M Brink, and S K Wadman, and I Lombeck
January 1986, Journal of inherited metabolic disease,
M Duran, and F A Beemer, and C van de Heiden, and J Korteland, and P K de Bree, and M Brink, and S K Wadman, and I Lombeck
January 1996, Journal of inherited metabolic disease,
M Duran, and F A Beemer, and C van de Heiden, and J Korteland, and P K de Bree, and M Brink, and S K Wadman, and I Lombeck
January 1985, Virchows Archiv. A, Pathological anatomy and histopathology,
M Duran, and F A Beemer, and C van de Heiden, and J Korteland, and P K de Bree, and M Brink, and S K Wadman, and I Lombeck
December 1988, European journal of pediatrics,
M Duran, and F A Beemer, and C van de Heiden, and J Korteland, and P K de Bree, and M Brink, and S K Wadman, and I Lombeck
January 1991, Journal of inherited metabolic disease,
M Duran, and F A Beemer, and C van de Heiden, and J Korteland, and P K de Bree, and M Brink, and S K Wadman, and I Lombeck
December 1983, Lancet (London, England),
M Duran, and F A Beemer, and C van de Heiden, and J Korteland, and P K de Bree, and M Brink, and S K Wadman, and I Lombeck
January 1985, Journal of inherited metabolic disease,
M Duran, and F A Beemer, and C van de Heiden, and J Korteland, and P K de Bree, and M Brink, and S K Wadman, and I Lombeck
November 1986, Annales de pediatrie,
M Duran, and F A Beemer, and C van de Heiden, and J Korteland, and P K de Bree, and M Brink, and S K Wadman, and I Lombeck
December 1996, Nihon rinsho. Japanese journal of clinical medicine,
M Duran, and F A Beemer, and C van de Heiden, and J Korteland, and P K de Bree, and M Brink, and S K Wadman, and I Lombeck
November 2012, Journal of inherited metabolic disease,
Copied contents to your clipboard!